The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
What is the survival length from the late lines of treatment in metastatic breast cancer?
M. Mouret-Reynier
No relevant relationships to disclose
E. Planchat
No relevant relationships to disclose
E. Thivat
No relevant relationships to disclose
C. Abrial
No relevant relationships to disclose
C. Pomel
No relevant relationships to disclose
P. Dubray-Longeras
No relevant relationships to disclose
H. Devaud
No relevant relationships to disclose
B. Nayl
No relevant relationships to disclose
A. Dillies
No relevant relationships to disclose
Q. Wang-Lopez
No relevant relationships to disclose
P. J. M. Chollet
No relevant relationships to disclose
H. Cure
No relevant relationships to disclose
J. Nabholtz
No relevant relationships to disclose
X. Durando
No relevant relationships to disclose